$169 Million is the total value of PURA VIDA INVESTMENTS, LLC's 66 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGEN | Exit | AGENUS INCcall | $0 | – | -65,700 | -100.0% | -0.09% | – |
NSTG | Exit | NANOSTRING TECHNOLOGIES INCcall | $0 | – | -29,300 | -100.0% | -0.09% | – |
CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -25,000 | -100.0% | -0.09% | – |
KDMN | Exit | KADMON HLDGS INC | $0 | – | -200,000 | -100.0% | -0.30% | – |
ABLX | Exit | ABLYNX NVsponsored adr | $0 | – | -29,399 | -100.0% | -0.31% | – |
ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -35,000 | -100.0% | -0.31% | – |
KURA | Exit | KURA ONCOLOGY INC | $0 | – | -50,000 | -100.0% | -0.32% | – |
CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -60,000 | -100.0% | -0.34% | – |
PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -10,000 | -100.0% | -0.41% | – |
QTRX | Exit | QUANTERIX CORP | $0 | – | -49,300 | -100.0% | -0.44% | – |
TSRO | Exit | TESARO INC | $0 | – | -15,000 | -100.0% | -0.52% | – |
ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -20,400 | -100.0% | -0.54% | – |
PEN | Exit | PENUMBRA INC | $0 | – | -15,000 | -100.0% | -0.59% | – |
DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -68,154 | -100.0% | -0.65% | – |
CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -275,000 | -100.0% | -0.78% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -5,000 | -100.0% | -0.79% | – |
HCA | Exit | HCA HEALTHCARE INCcall | $0 | – | -25,000 | -100.0% | -0.92% | – |
ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -30,000 | -100.0% | -0.94% | – |
MEDP | Exit | MEDPACE HLDGS INC | $0 | – | -70,000 | -100.0% | -1.06% | – |
PODD | Exit | INSULET CORP | $0 | – | -40,000 | -100.0% | -1.16% | – |
VAR | Exit | VARIAN MED SYS INCput | $0 | – | -25,000 | -100.0% | -1.16% | – |
ISRG | Exit | INTUITIVE SURGICAL INCcall | $0 | – | -8,000 | -100.0% | -1.22% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB COput | $0 | – | -50,000 | -100.0% | -1.28% | – |
EVHC | Exit | ENVISION HEALTHCARE CORP | $0 | – | -90,000 | -100.0% | -1.30% | – |
GMED | Exit | GLOBUS MED INCcall | $0 | – | -78,600 | -100.0% | -1.35% | – |
CVS | Exit | CVS HEALTH CORPcall | $0 | – | -45,000 | -100.0% | -1.36% | – |
DXCM | Exit | DEXCOM INCput | $0 | – | -56,900 | -100.0% | -1.37% | – |
AXGN | Exit | AXOGEN INC | $0 | – | -120,000 | -100.0% | -1.42% | – |
HOLX | Exit | HOLOGIC INC | $0 | – | -90,000 | -100.0% | -1.61% | – |
HCA | Exit | HCA HEALTHCARE INC | $0 | – | -45,000 | -100.0% | -1.65% | – |
VNDA | Exit | VANDA PHARMACEUTICALS INCput | $0 | – | -300,000 | -100.0% | -1.91% | – |
WBA | Exit | WALGREENS BOOTS ALLIANCE INCcall | $0 | – | -65,000 | -100.0% | -1.98% | – |
MZOR | Exit | MAZOR ROBOTICS LTDput | $0 | – | -92,300 | -100.0% | -1.99% | – |
BSX | Exit | BOSTON SCIENTIFIC CORPput | $0 | – | -230,000 | -100.0% | -2.39% | – |
XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -92,500 | -100.0% | -2.55% | – |
IBB | Exit | ISHARES TRput | $0 | – | -65,000 | -100.0% | -2.90% | – |
IWM | Exit | ISHARES TRput | $0 | – | -47,500 | -100.0% | -3.03% | – |
XBI | Exit | SPDR SER TRput | $0 | – | -87,500 | -100.0% | -3.11% | – |
FXH | Exit | FIRST TR EXCHANGE TRADED FDput | $0 | – | -130,000 | -100.0% | -3.80% | – |
LIVN | Exit | LIVANOVA PLCcall | $0 | – | -128,000 | -100.0% | -4.28% | – |
OSIS | Exit | OSI SYSTEMS INCcall | $0 | – | -201,500 | -100.0% | -5.43% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.